Home › Funds › GAGNON SECURITIES LLC › TMCI
GAGNON SECURITIES LLC position in TMCI
TREACE MED CONCEPTS INC · Health Care
GAGNON SECURITIES LLC reported holding 3,415,918 shares of TMCI (TREACE MED CONCEPTS INC) in its Q3 2026 13F filing — a position valued at US$15.2M, representing 2.63% of its reported portfolio and ranking #15 among its reported holdings. GAGNON SECURITIES LLC has disclosed TMCI holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GAGNON SECURITIES LLC's TMCI position evolved
GAGNON SECURITIES LLC first disclosed a stake in TMCI in Q2 2024 at 483,581 shares (US$3.2M). The position peaked in Q3 2026 at 3,415,918 shares, worth US$15.2M. Across 10 filings, GAGNON SECURITIES LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,415,918 shares valued at US$15.2M — an increase of 386,375 shares quarter over quarter.. Notable position changes include a 266% increase in Q3 2024 (shares rose 28% over the following quarter), a 67% increase in Q1 2026 (shares rose 197% over the following quarter), a 42% trim in Q2 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 483.58K | $3.22M | New |
| Q3 2024 | 1.77M | $10.27M | Add |
| Q4 2024 | 1.77M | $13.15M | Hold |
| Q1 2025 | 1.75M | $14.65M | Reduce |
| Q2 2025 | 2.25M | $13.23M | Add |
| Q3 2025 | 2.26M | $15.15M | Hold |
| Q4 2025 | 3.11M | $7.62M | Add |
| Q1 2026 | 5.20M | $6.97M | Add |
| Q2 2026 | 3.03M | $12.06M | Reduce |
| Q3 2026 | 3.42M | $15.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMCI and 13F data
TMCI (TREACE MED CONCEPTS INC) is a Health Care company. 19 other funds we track also report a position in TMCI — the largest reported positions include ARMISTICE CAPITAL, LLC (US$25.3M), Gagnon Advisors, LLC (US$6.8M), WEBER CAPITAL MANAGEMENT LLC /ADV (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMCI
- ARMISTICE CAPITAL, LLC 6.36M sh · $25.33M · Q2 2026
- Gagnon Advisors, LLC 1.53M sh · $6.81M · Q3 2026
- WEBER CAPITAL MANAGEMENT LLC /ADV 589.62K sh · $2.62M · Q3 2026
More on GAGNON SECURITIES LLC
FAQ
How long has GAGNON SECURITIES LLC held TMCI?
GAGNON SECURITIES LLC has disclosed TMCI holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is GAGNON SECURITIES LLC's current position in TMCI?
As of Q3 2026, GAGNON SECURITIES LLC holds 3.42M shares of TMCI (TREACE MED CONCEPTS INC), valued at $15.17M, representing 2.63% of its reported portfolio and ranking #15.
Has GAGNON SECURITIES LLC been buying or selling TMCI?
In the latest 13F filing (Q3 2026), GAGNON SECURITIES LLC increased its position in TMCI. The position peaked in Q3 2026 at 3.42M shares.
Which other funds hold TMCI?
Other major institutional holders of TMCI include ARMISTICE CAPITAL, LLC, Gagnon Advisors, LLC, WEBER CAPITAL MANAGEMENT LLC /ADV, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.